Lewis R. Silverman
- ASSOCIATE PROFESSOR Medicine, Hematology and Medical Oncology
- ASSISTANT PROFESSOR Oncological Sciences
Print Profile
Specialty
Certifications
Medical Oncology
Hematology
American Board of Internal Medicine
Education
MD, University of Brussels
Residency, Internal Medicine
Metropolitan Hospital CenterResidency, Internal Medicine
Montefiore Medical CenterFellowship, Hematology
Montefiore Medical CenterFellowship, Neopalstic Diseases
Mount Sinai Hospital
Publications
Benisovich VI, Silverman L, Stone N, Cohen E. Cisplatin-based chemotherapy in renal transplant recipients. A case report and a review of the literature. Cancer 1996; 77(1): 160-163.
Clinical Trials
- Phase I 01910.Na Infusion w/Leukemia or Myelodyspastic MDS
- Phase I-II Study of Vorinostat Combined with Azacitidine
- Phase I Dose Escalation Study of ON 01910.Na with Increasing Duration of an Initial 3-Day Continuous Infusion in Patients with Refractory Leukemia or Myelodysplastic Syndrome (MDS)
- A Phase III, Multi-Center, Randomized, Controlled Study to Assess the Efficacy and Safety of ON 01910.Na administered as a 72-hour continuous intravenous infusion every other week in MDS patients with excess blasts relapsing after, or refractory to, or intolerant to Azacitidine or Decitabine
- A Phase 2, Multi-Center, Open Label, Randomized, Parallel-Group Study of A Lenalidomide (Revlimid) Regimen or A Sequential Azacitidine (Vidaza) plus Lenalidomide (Revlimid) Regimen versus Conventional Care for Therapy of Subjects 65 Years or Older with Newly Diagnosed Acute Myeloid Leukemia
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Silverman during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Incyte-Novartis Coporation partnership; Merck & Co., Inc.; Onconova Therapeutics, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
1470 Madison Avenue
3rd floor
New York, NY 10029
Fax: 212-348-9233
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm